Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Cryosurgical Freezing and Intratumoral Combination Immunotherapy in Men With Metastatic Prostatic Adenocarcinoma

NCT04090775 is registered in ClinicalTrials.gov with Rampart Health, L.L.C. as lead sponsor.

NCT NCT04090775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Cryosurgical Freezing and Intratumoral Combination Immunotherapy in Men With Metastatic Prostatic Adenocarcinoma
Lead sponsor
Rampart Health, L.L.C.
Phase
Phase 2
Overall status
Completed
Start date
June 28, 2019
Completion date
January 31, 2022
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostatic adenocarcinoma